Actively Recruiting
Early Biomarkers Study for Unilateral Ureteropelvic Junction Obstruction in Children Aged 0 to 5 Years
Led by University of Campania Luigi Vanvitelli · Updated on 2024-04-30
85
Participants Needed
5
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to learn about specific biomarkers related to unilateral ureteropelvic junction obstruction UPJO in children aged 0 to 5 years who undergo surgery for this condition compared with children without hydronephrosis needing surgery for other reasons. UPJO is a blockage that affects urine flow from the kidney to the ureter, which can cause kidney damage. The study focuses on improving diagnosis and risk assessment through blood and urine tests rather than relying solely on imaging. Children in the study will have urinary single-cell and extracellular vesicle screenings to explore kidney injury and repair processes, along with whole blood gene expression profiling to identify early markers of UPJO. The study will compare data from 35 children with unilateral UPJO and 50 control children who require surgery for other conditions like hernia or hydrocele. The research does not involve treatment but collects diagnostic information. Participants will undergo collection of urine and blood samples over a period of up to 48 months to measure biomarkers. Researchers will analyze these samples to better understand kidney damage mechanisms and improve early diagnosis of UPJO. This long-term observation aims to reduce unnecessary surgeries and the risks of delayed treatment by identifying precise biomarkers. The study is observational and does not involve any experimental therapies.
CONDITIONS
Brief Title
The PRO-FUTURE Project
Research Team
P
Pierluigi Marzuillo, MD PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here